PetMed Express, Inc.: stock overview

PETSNASDAQConsumer defensive · Retail-Drug Stores and Proprietary Stores

Price

$0.94

November 13, 2026Market cap $20M

DCF calculator

What Ploutos Investor adds for PetMed Express

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from FY2010
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 22% since Nov 10, 2026, when the 10-Q these figures come from was filed ($1.21 then, $0.94 on Nov 13, 2026). The figures date from before that move.10-Q

In short

PetMed Express had revenue of $160M over the last 12 months and a net loss of $27M. Revenue fell by 10.0% a year on average over the last 5 years. It holds more cash than debt, by $11M. It pays no dividend.

From its SEC filings (latest fiscal year to March 31, 2026) and the price of November 13, 2026.

Its SEC filings
Market cap
$20M
21.37M shares
P/E
–
Revenue, 12 months
$160M
-10.0% a year over 5 years
Net margin
-17.0%
FY2025: -32.0%, above 5% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2024–FY2026 fiscal years

-19.2% a year over 2 years

  • FY2026Mar 31, 202610-K
    Revenue$179M
  • FY2025Mar 31, 202510-K
    Revenue$227M
  • FY2024Mar 31, 202410-K
    Revenue$274M

Fiscal years in figures

PETS's revenue, profit, cash flow and dividend with each year-end price, from FY2010 to FY2023, 14 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $87M
$20M
Enterprise value 
$8.7M
P/E 
–
EV / EBIT 
–
EV / Revenue 
0.1
P/B 3-year median: 1.0
1.2
FCF yield 3-year median: -0.5%
–
Earnings yield 3-year median: -7.7%
–

Profitability

Gross margin 
27.8%
Operating margin 
-18.0%
Net margin 3-year median: -2.8%
-17.0%
ROIC 
-78.7%
ROIC, 5-year average 
2.9%
ROE 
-94.0%

Growth

Revenue, yearly change 
-21.1%
EPS, yearly change 
–
FCF, yearly change 
–
Revenue, average a year 
-10.0%

The yearly change compares FY2026 with FY2025.

Balance sheet

Cash 
$11M
Total debt 
$291.0K
Of which operating leases 
$291.0K
Net cash 
$11M
Net debt / EBITDA 
–
Interest cover 
–
Current ratio 
0.60

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 3-year median: 0.2%
0.00%
Buybacks 
–
Total returned 
0.00%
Shares, yearly change 
+3.4%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 59).

Gross margin

28.1%

Above 32% of the 51 companies in its industry, and 35% of all.

Operating margin

-32.8%

Above 4% of the 65 companies in its industry, and 10% of all.

Net margin

-32.0%

Above 5% of the 66 companies in its industry, and 10% of all.

ROE

-174.9%

Above 3% of the 46 companies in its industry, and 2% of all.

ROA

-65.1%

Above 4% of the 64 companies in its industry, and 2% of all.

Revenue growth

-21.1%

Above 4% of the 66 companies in its industry, and 4% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
PETMED EXPRESS INC
CIK
1040130
Exchange
NASDAQ
Industry (SIC)
5912 · Retail-Drug Stores and Proprietary Stores
Fiscal year ends
March 31
Latest annual report
March 31, 2026
Reporting currency
USD
Shares
21.37M

Other companies: Consumer defensive

The largest companies of the same sector, each with its own page.

The Consumer defensive sectorAll companies

The full analysis

What do PetMed Express's filings show?

These are PetMed Express's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about PETS

Didn't find what you were looking for?

Ask us
What is PETS's market cap?

PetMed Express, Inc.'s market cap is $20M, at a price of $0.94 on November 13, 2026 and 21.37M shares.

How much revenue does PETS have?

PetMed Express had revenue of $160M over the last 12 months. Over the last 5 years it changed by -10.0% a year on average.

Does PETS pay a dividend?

No. PetMed Express paid no regular dividend over the last 12 months.

Where do the figures come from?

From PetMed Express, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.